Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)
Egypt flag Egypt · Delayed Price · Currency is EGP
1.590
+0.020 (1.27%)
At close: Oct 4, 2026

EGX:MCRO Financials Overview

Millions EGP. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
982.42894.54519.97526.01729.61594.26
Revenue Growth
52.35%72.04%-1.15%-27.91%22.78%38.04%
Gross Profit
682.51609.24323.12295.65561.64473.87
Operating Income
148.47135.4512.03-182.39234.35203.62
Net Income
126.65115.73-38.1-272.65173.84147.93
Earnings Per Share
0.150.20-0.07-0.480.300.26
EPS Growth
34.82%---17.09%11.40%

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Egypt
863.75485.3510.98699.15587.43
Export
30.834.6715.0230.466.83
Total
894.54519.97526.01729.61594.26

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
475.79176.0462.3475.31186.7560.67
Total Debt
43.07333.43316.32226.18204.6597.81
Net Cash (Debt)
432.71-157.39-253.98-150.87-17.89-37.14
Net Cash Growth
------
Net Cash Per Share
0.51-0.28-0.45-0.27-0.03-0.06

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
82.88160.99-74.45-38.01134.9350.26
Capital Expenditures
-34.85-42.48-12.32-6.44-5.3-5.81
Free Cash Flow
48.03118.51-86.76-44.44129.6344.44
Free Cash Flow Growth
----191.66%14.31%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
69.47%68.11%62.14%56.21%76.98%79.74%
Operating Margin
15.11%15.14%2.31%-34.67%32.12%34.26%
Pretax Margin
14.63%13.63%-7.61%-51.34%31.16%33.06%
Profit Margin
12.89%12.94%-7.33%-51.83%23.83%24.89%
FCF Margin
4.89%13.25%-16.69%-8.45%17.77%7.48%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.107---0.1070.069
Dividend Per Share Growth
----54.70%-
Dividend Yield
6.71%---15.40%-

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
10.775.62--10.76-
Forward PE
22.7110.0710.0710.0710.07-
P/FCF Ratio
113.265.49--14.43-
PS Ratio
5.540.732.543.202.56-